Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Vaxart Inc (VXRT)

Vaxart Inc (VXRT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.4212 -0.0358 (-7.83%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.4333 +0.0121 (+2.87%) 19:33 ET
Quote Overview for Fri, Mar 28th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.4200
Day High
0.4613
Open 0.4613
Previous Close 0.4570 0.4570
Volume 1,923,700 1,923,700
Avg Vol 1,721,795 1,721,795
Stochastic %K 6.13% 6.13%
Weighted Alpha -65.09 -65.09
5-Day Change -0.0949 (-18.39%) -0.0949 (-18.39%)
52-Week Range 0.4200 - 1.3400 0.4200 - 1.3400
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 96,012
  • Shares Outstanding, K 227,949
  • Annual Sales, $ 28,700 K
  • Annual Income, $ -66,950 K
  • EBIT $ -66 M
  • EBITDA $ -58 M
  • 60-Month Beta 1.69
  • Price/Sales 3.63
  • Price/Cash Flow N/A
  • Price/Book 1.76
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.34
  • Most Recent Earnings $-0.05 on 03/20/25
  • Next Earnings Date 05/12/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Options Overview Details

View History
  • Implied Volatility 148.56% ( -80.61%)
  • Historical Volatility 125.50%
  • IV Percentile 25%
  • IV Rank 27.84%
  • IV High 455.61% on 07/18/24
  • IV Low 30.12% on 10/22/24
  • Put/Call Vol Ratio 0.33
  • Today's Volume 164
  • Volume Avg (30-Day) 162
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 11,611
  • Open Int (30-Day) 11,763

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.06
  • Low Estimate -0.07
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +57.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4200 +0.29%
on 03/28/25
Period Open: 0.5093
0.5978 -29.54%
on 03/18/25
-0.0881 (-17.30%)
since 02/28/25
3-Month
0.4200 +0.29%
on 03/28/25
Period Open: 0.7308
0.9800 -57.02%
on 01/07/25
-0.3096 (-42.36%)
since 12/27/24
52-Week
0.4200 +0.29%
on 03/28/25
Period Open: 1.3000
1.3400 -68.57%
on 04/01/24
-0.8788 (-67.60%)
since 03/28/24

Most Recent Stories

More News
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VXRT : 0.4212 (-7.83%)
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results

VXRT : 0.4212 (-7.83%)
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20

VXRT : 0.4212 (-7.83%)
Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate

VXRT : 0.4212 (-7.83%)
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults

VXRT : 0.4212 (-7.83%)
Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors

VXRT : 0.4212 (-7.83%)
Vaxart Highlights Progress of COVID-19, Norovirus and Influenza Programs

VXRT : 0.4212 (-7.83%)
Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial

VXRT : 0.4212 (-7.83%)
Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

VXRT : 0.4212 (-7.83%)
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VXRT : 0.4212 (-7.83%)

Business Summary

Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick...

See More

Key Turning Points

3rd Resistance Point 0.4896
2nd Resistance Point 0.4755
1st Resistance Point 0.4483
Last Price 0.4212
1st Support Level 0.4070
2nd Support Level 0.3929
3rd Support Level 0.3657

See More

52-Week High 1.3400
Fibonacci 61.8% 0.9886
Fibonacci 50% 0.8800
Fibonacci 38.2% 0.7714
Last Price 0.4212
52-Week Low 0.4200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies